Gender
Oral Anti-Inflammatory Asthma Drugs (Leukotriene Receptor Antagonists And Inhibitors Of Lipo-Oxygenase) (Sleep Heart Health Study Visit Two (SHHS2)) vs Sleep Heart Health Study (SHHS) Visit Number
| Visit 1 | Interim Follow-up Visit | Visit 2 | CVD Outcomes | |
|---|---|---|---|---|
| Total | - | - | 4,080 | - |
| No | - | - | 3,581 | - |
| Yes | - | - | 39 | - |
| Unknown | - | - | 460 | - |
Oral Anti-Inflammatory Asthma Drugs (Leukotriene Receptor Antagonists And Inhibitors Of Lipo-Oxygenase) (Sleep Heart Health Study Visit Two (SHHS2)) vs Gender of the participant
Visit 2
| Male | Female | Total | |
|---|---|---|---|
| Total | 1,861 | 2,219 | 4,080 |
| No | 1,646 | 1,935 | 3,581 |
| Yes | 15 | 24 | 39 |
| Unknown | 200 | 260 | 460 |
Oral Anti-Inflammatory Asthma Drugs (Leukotriene Receptor Antagonists And Inhibitors Of Lipo-Oxygenase) (Sleep Heart Health Study Visit Two (SHHS2)) vs Race of the participant
Visit 2
| White | Black | Other | Total | |
|---|---|---|---|---|
| Total | 3,587 | 256 | 237 | 4,080 |
| No | 3,131 | 237 | 213 | 3,581 |
| Yes | 31 | 5 | 3 | 39 |
| Unknown | 425 | 14 | 21 | 460 |